Neuralink's Third Patient Breaks Ground with First Video Edited Using Brain Chip

Elon Musk's Neuralink has made significant strides in brain-computer interface (BCI) technology with the installation of its third brain chip in a human patient. This patient, Bradford G. Smith, who is living with Amyotrophic Lateral Sclerosis (ALS), has shared a groundbreaking video showcasing his experiences and newfound abilities, including editing the video using only his thoughts.

Key Takeaways

• Bradford G. Smith is the third patient to receive a Neuralink brain chip and the first with ALS.

• He has regained the ability to communicate and control devices using the BCI.

• The video he shared is the first to be edited directly with a BCI, narrated by an AI-generated version of his voice.

• Neuralink aims to restore autonomy to individuals with severe mobility impairments.

The Journey of Bradford G. Smith

Bradford G. Smith's journey with Neuralink began when he became the third participant in the company's clinical trials. As the first non-verbal patient with ALS to receive the implant, Smith's experience is particularly significant. In a recent video, he detailed how the BCI has transformed his life, allowing him to communicate more effectively than with previous technologies, such as eye trackers.

Smith expressed his excitement, stating, "I am typing this with my brain. It is my primary communication." This statement highlights the profound impact the BCI has had on his ability to interact with the world around him.

Features of the BCI

The Neuralink BCI has several features that set it apart from traditional assistive technologies:

• Enhanced Communication: Smith can now communicate in various environments, including outdoors, which was previously challenging with his eye tracker.

• Device Control: The BCI allows him to control external devices, such as computers, with ease, showcasing its versatility.

• AI Integration: The video Smith shared was narrated by an AI-generated version of his voice, demonstrating the potential for personalized communication.

Impact on Daily Life

In his video, Smith shared several personal milestones that he has achieved since receiving the BCI:

1. Outdoor Communication: For the first time in years, he was able to talk outside, even during his child's soccer game.

2. Family Engagement: He attended his child's robotics award ceremony, a significant event he could not participate in before.

3. Exploration: Smith is considering traveling outside the city for the first time in five years, a testament to the newfound autonomy the BCI has provided.

Future of Neuralink Trials

Neuralink's clinical trials are focused on restoring autonomy to individuals with severe mobility impairments. The company received FDA approval to begin human trials in May 2023, and Smith's progress is a promising indicator of the technology's potential.

Neuralink has also opened its Patient Registry, inviting participants to join its studies. The company plans to expand its operations, with a new study location set to open in Miami, Florida, in January 2024.

Conclusion

Bradford G. Smith's experience as Neuralink's third brain chip patient marks a significant milestone in the field of brain-computer interfaces. His ability to communicate and control devices using only his thoughts not only showcases the potential of this technology but also offers hope to many individuals facing similar challenges. As Neuralink continues its trials, the future looks promising for advancements in assistive technologies that can enhance the quality of life for those with severe disabilities.